Name Funds
holding
Growth Growth % Return since
30 Sep ‘18
5026
2 -1 -33% 88.7%
5027
2 -1 -33% 98.3%
5028
2 -1 -33% 120%
ENLV icon
5029
Enlivex Therapeutics
ENLV
$26.7M
2 -1 -33% 89.8%
5030
2 -1 -33% 98.1%
5031
2 -1 -33% 40.9%
5032
4 -2 -33% 57.2%
5033
4 -2 -33% 50.5%
5034
4 -2 -33% 78.5%
5035
4 -2 -33% 69.4%
UPV icon
5036
ProShares Ultra FTSE Europe
UPV
$9.46M
6 -3 -33% 54.8%
5037
6 -3 -33% 33.6%
5038
6 -3 -33% 14.8%
5039
6 -3 -33% 64.3%
5040
8 -4 -33% 8.89%
5041
11 -6 -35% 41.5%
5042
9 -5 -36% 72.6%
5043
9 -5 -36% 0.61%
5044
16 -9 -36% 9.09%
5045
7 -4 -36% 20.3%
5046
7 -4 -36% 31.2%
5047
12 -7 -37% 32%
5048
5 -3 -38% 17.1%
5049
5 -3 -38% 64.8%
5050
3 -2 -40% 90%